Actieve functies van Bruce Seligmann
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioSypder Technologies, Inc.
BioSypder Technologies, Inc. Medical SpecialtiesHealth Technology BioSpyder Technologies, Inc. is a biotechnology company based in Carlsbad, CA. BioSpyder Technologies has developed a novel product for targeted sequencing called Tempo-Seq, which is a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. Tempo-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. The assay content is flexible and customizable, delivering unprecedented accuracy and sensitivity with simplified data analysis that eliminates the need for bioinformatics. Tempo-Seq assays deliver an easy-to-use solution for customers doing expression profiling for any species. The private company was founded in 2011 by Joel McComb, Bruce Seligmann, and Joanne Yeakley, with Joel McComb serving as the CEO since then. | Hoofd Techniek/Wetenschap/O&O | 01-12-2012 | - |
Oprichter | 01-12-2012 | - |
Loopbaan van Bruce Seligmann
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
BioSypder Technologies, Inc.
BioSypder Technologies, Inc. Medical SpecialtiesHealth Technology BioSpyder Technologies, Inc. is a biotechnology company based in Carlsbad, CA. BioSpyder Technologies has developed a novel product for targeted sequencing called Tempo-Seq, which is a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. Tempo-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. The assay content is flexible and customizable, delivering unprecedented accuracy and sensitivity with simplified data analysis that eliminates the need for bioinformatics. Tempo-Seq assays deliver an easy-to-use solution for customers doing expression profiling for any species. The private company was founded in 2011 by Joel McComb, Bruce Seligmann, and Joanne Yeakley, with Joel McComb serving as the CEO since then. | Health Technology |
- Beurs
- Insiders
- Bruce Seligmann
- Ervaring